Svas Biosana S.p.A. (BIT:SVS)
8.66
+0.04 (0.46%)
At close: Oct 10, 2025
Svas Biosana Revenue
Svas Biosana had revenue of 71.70M EUR in the half year ending June 30, 2025, with 26.06% growth. This brings the company's revenue in the last twelve months to 134.95M, up 9.02% year-over-year. In the year 2024, Svas Biosana had annual revenue of 122.29M with 0.54% growth.
Revenue (ttm)
134.95M
Revenue Growth
+9.02%
P/S Ratio
0.34
Revenue / Employee
385.58K
Employees
327
Market Cap
46.02M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 122.29M | 656.90K | 0.54% |
Dec 31, 2023 | 121.63M | 22.12M | 22.22% |
Dec 31, 2022 | 99.51M | 17.52M | 21.37% |
Dec 31, 2021 | 81.99M | 4.72M | 6.11% |
Dec 31, 2020 | 77.27M | -23.22M | -23.11% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Recordati Industria Chimica e Farmaceutica | 2.48B |
DiaSorin | 1.22B |
Amplifon | 2.41B |
Philogen | 84.66M |
EL.En. | 579.71M |
Safilo Group | 998.89M |
GPI S.p.A. | 531.42M |
Pharmanutra | 122.25M |